Compound class:
Synthetic organic
Comment: M201-A is a novel ryanodine receptor 2 (RyR2) inhibitor [1]. It was principally designed for the treatment of heart failure.
|
|
References |
1. Kaneko N, Loughrey CM, Smith G, Matsuda R, Hasunuma T, Mark PB, Toda M, Shinozaki M, Otani N, Kayley S et al.. (2024)
A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic actions: Preclinical and phase I study. Br J Pharmacol, 181 (18): 3401-3419. [PMID:38773354] |